Physician profile
Lee E Reid
NPI 1639657968
$1,467.19
in general payments reported to CMS, 2019-2025
16 companies · $15.20 in 2025
The $15.20 reported for 2025 was less than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $835 · 2022: $349 · 2023: $203 · 2024: $65.26 · 2025: $15.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $283.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $277.71 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $253.19 | 2021-2024 | Jardiance |
| Boston Scientific Corporation | $201.67 | 2021-2022 | |
| Atricure, INC. | $168.16 | 2023 | |
| Janssen Pharmaceuticals, INC | $167.30 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $80.39 | 2021-2022 | |
| Amgen INC. | $63.84 | 2021-2025 | Repatha |
| Abbott Laboratories | $45.00 | 2021-2022 | |
| Vifor Pharma, INC. | $40.75 | 2021 | |
| Amarin Pharma, INC. | $37.49 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $32.75 | 2021-2022 | |
| Daiichi Sankyo INC. | $28.55 | 2021 | |
| Merck Sharp & Dohme LLC | $26.00 | 2021-2022 | |
| Angiodynamics, INC. | $20.90 | 2023 | Auryon Laser System 100-120 Vac |
| E.R. Squibb & Sons, L.L.C. | $11.76 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $11.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Reid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.